ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Nine Saturation Program Planning Winners Names NCI May Reissue RFP Later This Year

May 23, 1975

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

In Brief: Seffrin’s ACS Appointment Is Official; Liotta Selected As NIH; Strategic Plan Meetings

June 12, 1992

California To Help Uninsured Get Prostate Cancer Therapy.

July 13, 2001

Waxman urges drug companies to list clinical trials on NIH Web site.

June 18, 2004